Actinium Pharma Highlights Abstracts Accepted for Oral and Poster Presentation at the EANM 2023 Congress
/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today...
Matthew Beck Astellas Pharma Oncology Lg Chem Life Sciences Exchange Commission Prnewswire Actinium Pharmaceuticals Inc European Association Of Nuclear Medicine
Source: prnewswire.com